STZ | ||
|---|---|---|
OUTLOOK RATING 1..100 | 9 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 20 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 41 | |
PRICE GROWTH RATING 1..100 | 63 | |
P/E GROWTH RATING 1..100 | 86 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| PSL | STZ | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 83% | 3 days ago 71% |
| Stochastic ODDS (%) | 3 days ago 75% | 3 days ago 36% |
| Momentum ODDS (%) | 3 days ago 79% | 3 days ago 53% |
| MACD ODDS (%) | 3 days ago 86% | 3 days ago 60% |
| TrendWeek ODDS (%) | 3 days ago 78% | 3 days ago 56% |
| TrendMonth ODDS (%) | 3 days ago 71% | 3 days ago 51% |
| Advances ODDS (%) | N/A | 11 days ago 51% |
| Declines ODDS (%) | N/A | 26 days ago 59% |
| BollingerBands ODDS (%) | 3 days ago 81% | 3 days ago 62% |
| Aroon ODDS (%) | 3 days ago 68% | 3 days ago 40% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| PGRSX | 10.90 | 0.17 | +1.58% |
| Principal Global Real Estate Sec R6 | |||
| SHPAX | 22.81 | 0.16 | +0.71% |
| Saratoga Health & Biotechnology A | |||
| FDEIX | 30.47 | 0.02 | +0.07% |
| Fidelity Advisor Capital Development I | |||
| APSRX | 17.42 | N/A | N/A |
| NYLI Fiera SMID Growth Class A | |||
| IPOAX | 24.97 | -0.37 | -1.46% |
| Nomura Systematic Emerging Markets Eq A | |||
A.I.dvisor indicates that over the last year, PSL has been closely correlated with SYY. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if PSL jumps, then SYY could also see price increases.